Jump Financial’s Indaptus Therapeutics INDP Stock Holding History

Jump Financial’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$63.6K	Buy	+27,662	New	+$59K	﹤0.01%	2233

Other funds holding INDP

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Jump Financial's INDP Position: Q3 2026 in Review

Jump Financial opened a new position in Indaptus Therapeutics (INDP) in Q3 2026: 27,662 shares worth $63.6K. The stake represents ﹤0.01% of the portfolio and ranks #2233 among its holdings.

15 funds tracked by Wall St. Rank hold INDP as of Q3 2026.

Jump Financial held 27,662 shares of Indaptus Therapeutics worth $63.6K as of Q3 2026.
Indaptus Therapeutics was a new Jump Financial position in Q3 2026.
Indaptus Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2233 holding.
15 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.